PDF
(4437KB)
Abstract
Background: Dihydrogen (H2) is produced endogenously by the intestinal microbiota through the fermentation of diet carbohydrates. Over the past few years, numerous studies have demonstrated the significant therapeutic potential of H2 in various pathophysiological contexts, making the characterization of its production in laboratory species of major preclinical importance.
Methods: This study proposes an innovative solution to accurately monitor H2 production in free-moving rodents while respecting animal welfare standards. The developed device consisted of a wire rodent cage placed inside an airtight chamber in which the air quality was maintained, and the H2 concentration was continuously analyzed. After the airtightness and efficiency of the systems used to control and maintain air quality in the chamber were checked, tests were carried out on rats and mice with different metabolic phenotypes, over 12 min to 1-h experiments and repeatedly. H2 production rates (HPR) were obtained using an easy calculation algorithm based on a first-order moving average.
Results: HPR in hyperphagic Zucker rats was found to be twice as high as in control Wistar rats, respectively, 2.64 and 1.27 nmol.s−1 per animal. In addition, the ingestion of inulin, a dietary fiber, stimulated H2 production in mice. HPRs were 0.46 nmol.s−1 for animals under control diet and 1.99 nmol.s−1 for animals under inulin diet.
Conclusions: The proposed device coupled with our algorithm enables fine analysis of the metabolic phenotype of laboratory rats or mice with regard to their endogenous H2 production.
Keywords
hydrogen therapy
/
laboratory rodents
/
microbiota
/
molecular hydrogen
/
noninvasive monitoring device
Cite this article
Download citation ▾
Victor Pascal-Moussellard, Emilie Boucher, Stéphane Tanguy, Philippe Cinquin, Pierre-Alain Barraud, Chloé Davin, Cordélia Salomez-Ihl, Dalil Hannani, François Boucher, Jean-Pierre Alcaraz.
An ethically guided preclinical device for phenotyping H2 production in laboratory rodents.
Animal Models and Experimental Medicine, 2024, 7(4): 553-561 DOI:10.1002/ame2.12460
| [1] |
Liu Z, Perez-Gussinye M, García-Pintado J, Mezri L, Bach W. Mantle serpentinization and associated hydrogen flux at North Atlantic magma-poor rifted margins. Geology. 2023;51(3):284-289.
|
| [2] |
Hand E. Hidden hydrogen. Science (New York, NY). 2023;379(6633):630-636.
|
| [3] |
Mutuyemungu E, Singh M, Liu S, Rose DJ. Intestinal gas production by the gut microbiota: a review. J Funct Foods. 2023;100:105367.
|
| [4] |
Salomez-Ihl C, Tanguy S, Boucher F, et al. Development of a preclinical tool for measuring percutaneous transfer of dihydrogen, with a view to optimizing medical devices adapted to focal therapies in dermatology. In: Slezak J, Kura B, eds. Molecular Hydrogen in Health and Disease. Advances in Biochemistry in Health and Disease. 27th ed. Springer;2024:2142-2512.
|
| [5] |
Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med. 1969;281(3):122-127.
|
| [6] |
Newman A. Breath-analysis tests in gastroenterology. Gut. 1974;15(4):308-323.
|
| [7] |
Martel J, Chang SH, Ko YF, Hwang TL, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022;33(4):247-265.
|
| [8] |
Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39-49.
|
| [9] |
Sommer F, Bäckhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227-238.
|
| [10] |
Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55-71.
|
| [11] |
Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688-694.
|
| [12] |
Artamonov MY, Martusevich AK, Pyatakovich FA, Minenko IA, Dlin SV, LeBaron TW. Molecular hydrogen: from molecular effects to stem cells management and tissue regeneration. Antioxidants. 2023;12:636.
|
| [13] |
Lebaron TW, Ohno K, Hancock JT. The on/off history of hydrogen in medicine: will the interest persist this time around? Oxygen. 2023;3:143-162.
|
| [14] |
Cole AR, Raza A, Ahmed H, et al. Safety of inhaled hydrogen gas in healthy mice. Med Gas Res. 2019;9(3):133-138.
|
| [15] |
Salomez-Ihl C, Tanguy S, Alcaraz JP, et al. Hydrogen inhalation: in vivo rat genotoxicity tests. Mutat Res Genet Toxicol Environ Mutagen. 2024;894:503736.
|
| [16] |
Ito M, Hirayama M, Yamai K, et al. Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydroxydopamine-induced Parkinson’s disease in rats. Med Gas Res. 2012;2(1):15.
|
| [17] |
Gumbmann MR, Williams SN. The quantitative collection and determination of hydrogen gas from the rat and factors affecting its production. Proc Soc Exp Biol Med. 1971;137(4):1171-1175.
|
| [18] |
Hartmann L, Taras D, Kamlage B, Blaut M. A new technique to determine hydrogen excreted by gnotobiotic rats. Lab Anim. 2000;34(2):162-170.
|
| [19] |
Ebihara K, Tachibe M, Kaneko N, Kishida T. Hydroxypropylation of high-amylose maize starch changes digestion and fermentation-dependent parameters in rats. J Nutr Sci. 2013;2:e17.
|
| [20] |
Fernández-Calleja JM, Konstanti P, Swarts HJ, et al. Non-invasive continuous real-time in vivo analysis of microbial hydrogen production shows adaptation to fermentable carbohydrates in mice. Sci Rep. 2018;8(1):15351.
|
| [21] |
Shirokov IV, Ivanova AU, Trunov SS, Luzhnov PV, Medvedev OS. Experimental setup for measurements the hydrogen concentration in exhaled Rat’s air. 2020 Ural Symposium on Biomedical Engineering, Radioelectronics and Information Technology (USBEREIT).
|
| [22] |
Boucher E, Plazy C, Richard ML, et al. Inulin prebiotic reinforces host cancer immunosurveillance via ɣδ T cell activation. Front Immunol. 2023;14:1104224.
|
| [23] |
Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension. 1989;13:896-901.
|
| [24] |
Zheng Y, Zhang W, Pendleton E, et al. Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6K activities in the liver of obese Zucker rats. J Endocrinol. 2009;203(3):337-347.
|
| [25] |
Hakkak R, Korourian S, Foley SL, Erickson BD. Assessment of gut microbiota populations in lean and obese Zucker rats. PLoS One. 2017;12(7):e0181451.
|
| [26] |
Ichikawa Y, Yamamoto H, Hirano SI, Sato B, Takefuji Y, Satoh F. The overlooked benefits of hydrogen-producing bacteria. Med Gas Res. 2023;13(3):108-111.
|
| [27] |
Rezaie A, Buresi M, Membo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the north American consensus. Am J Gastroenterol. 2017;112(5):775-784.
|
| [28] |
Geboes KP, Luypaerts A, Rutgeerts P, Verbeke K. Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time. Aliment Pharmacol Ther. 2003;18(7):721-729.
|
| [29] |
Yu X, Gurry T, Nguyen LTT, Richardson HS, Alm EJ. Prebiotics and community composition influence gas production of the human gut microbiota. MBio. 2020;11(5): e00217-e00220.
|
| [30] |
Singh A, Zapata RC, Pezeshki A, Reidelberger RD, Chelikani PK. Inulin fiber dose-dependently modulates energy balance, glucose tolerance, gut microbiota, hormones and diet preference in high-fat-fed male rats. J Nutr Biochem. 2018;59:142-152.
|
| [31] |
Vandeputte D, Falony G, Vieira-Silva S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017;66(11):1968-1974.
|
| [32] |
Han K, Nam J, Xu J, et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nat Biomed Eng. 2021;5(11):1377-1388.
|
RIGHTS & PERMISSIONS
2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.